GlassScriptPhysician profile
Daniel A Sidhom
NPI 1134782402
$6,250.59
in general payments reported to CMS, 2019-2025
12 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.91 · 2022: $245 · 2023: $3,712 · 2024: $701 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,350 · Food and Beverage: $2,411 · Gift: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,350.25 |
| Food and Beverage | $2,411.34 |
| Gift | $151.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,129.73 | 2022-2023 | Ams 700, Lithovue |
| Intuitive Surgical, INC. | $1,546.78 | 2024-2025 | |
| Urogen Pharma, INC. | $325.46 | 2023-2024 | |
| Abbvie INC. | $221.13 | 2023-2024 | Botox |
| Kerecis Limited | $173.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Virtual Incision Corporation | $134.00 | 2024 | Mira |
| Olympus America INC. | $133.73 | 2022 | |
| Palette Life Sciences, INC. | $133.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2023 | Lynparza |
| Baxter Healthcare | $120.00 | 2024 | Floseal, Tisseel |
| Astellas Pharma US INC | $115.67 | 2023 | |
| Allergan, INC. | $91.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sidhom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.